Rukmini Mrudula

First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson’s Disease in Emiratis and Expatriate Population of United Arab Emirates 2019–2021: The EmPark Study

K. Chaudhuri, S. Mohan, H. Benamer, 2022, Journal of personalized medicine.

Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience

R. Borgohain, C. Falup-Pecurariu, V. Metta, 2023, Scientific reports.